Inhibition bone resorption

Details Inhibition bone resorption Inhibition bone resorption

A - Human Necessities

61

K

A61K 31/663 (2006.01) A61K 31/341 (2006.01) A61K 31/4164 (2006.01) A61K 31/425 (2006.01) A61K 31/4439 (2006.01) A61K 31/675 (2006.01) A61P 19/08 (2006.01)

Patent

CA 2349744

A bisphosphonate is employed in combination with a histamine H2 receptor blocker or a proton pump inhibitor for inhibiting bone resorption in accordance with a continuous schedule having a periodicity from about once every 3 days to about once every 16 days or at a dosing interval of once- weekly, twice weekly, bi-weekly or twice monthly.

Affiliated with

Also associated with

Rating

Inhibition bone resorption does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition bone resorption, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition bone resorption will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1723867